Search Results - "Fagerli, Karen M."

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register by Fagerli, Karen M, Kearsley-Fleet, Lianne, Mercer, Louise K, Watson, Kath, Packham, Jon, Symmons, Deborah P M, Hyrich, Kimme L

“…Abstract Objective The aim of this study was to compare the incidence of cancer and all-cause and cause-specific mortality rates among a cohort of patients…”
Get full text

Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD by Bardan, Imane, Fagerli, Karen M, Sexton, Joe, Kvien, Tore K, Bakland, Gunnstein, Mielnik, Pawel, Hu, Yi, Lien, Gunhild, Flatø, Berit, Molberg, Øyvind, Kristianslund, Eirik K, Aga, Anna-Birgitte

“…To compare the effectiveness of tumor necrosis factor inhibitors (TNFi) ± comedication and methotrexate (MTX) monotherapy between patients with adult juvenile…”
Get full text

Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network by Hellamand, Pasoon, Sande, Marleen G. H., Ørnbjerg, Lykke M., Klausch, Thomas, Eklund, Kari K., Relas, Heikki, Santos, Maria J., Vieira‐Sousa, Elsa, Loft, Anne G., Glintborg, Bente, Østergaard, Mikkel, Lindström, Ulf, Wallman, Johan K., Michelsen, Brigitte, Fagerli, Karen M., Castrejón, Isabel, Gudbjornsson, Bjorn, Love, Thorvardur J., Vencovský, Jiří, Nekvindová, Lucie, Rotar, Žiga, Tomšič, Matija, Díaz‐González, Federico, Kenar, Gökçe, Tuğsal, Handan Y., Iannone, Florenzo, Ramonda, Roberta, Codreanu, Catalin, Mogosan, Corina, Nissen, Michael J., Möller, Burkhard, Hetland, Merete L., Horst‐Bruinsma, Irene E.

“…Objective Women with psoriatic arthritis (PsA) may have reduced tumor necrosis factor inhibitor (TNFi) effectiveness compared to men. We examined sex…”
Get full text

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care by Ørnbjerg, Lykke M, Rugbjerg, Kathrine, Georgiadis, Stylianos, Rasmussen, Simon H, Jacobsson, Lennart, Loft, Anne G, Iannone, Florenzo, Fagerli, Karen M, Vencovsky, Jiri, Santos, Maria J, Möller, Burkhard, Pombo-Suarez, Manuel, Rotar, Ziga, Gudbjornsson, Bjorn, Cefle, Ayse, Eklund, Kari, Codreanu, Catalin, Jones, Gareth, van der Sande, Marleen, Wallman, Johan K, Sebastiani, Marco, Michelsen, Brigitte, Závada, Jakub, Nissen, Michael J, Sanchez-Piedra, Carlos, Tomšič, Matija, Love, Thorvardur J, Relas, Heikki, Mogosan, Corina, Hetland, Merete L, Østergaard, Mikkel

“…To evaluate patient-reported outcomes (PROs) after initiation of tumor necrosis factor inhibitor (TNFi) treatment in European real-world patients with…”
Get full text

Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16-45 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort by de Bruin, Freek, ter Horst, Simone, Bloem, Hans L, van den Berg, Rosaline, de Hooge, Manouk, van Gaalen, Floris, Fagerli, Karen M, Landewé, Robert, van Oosterhout, Maikel, van der Heijde, Désirée, Reijnierse, Monique

“…To determine the prevalence of degenerative changes (DCs) in the spine of young patients with back pain without axial spondyloarthritis (no-axSpA), with…”
Get full text

Impact of replacing radiographic sacroiliitis by magnetic resonance imaging structural lesions on the classification of patients with axial spondyloarthritis by Bakker, Pauline A, van den Berg, Rosaline, Hooge, Manouk de, van Lunteren, Miranda, Ez-Zaitouni, Zineb, Fagerli, Karen M, Landewé, Robert, van Oosterhout, Maikel, Ramonda, Roberta, Reijnierse, Monique, van Gaalen, Floris A, van der Heijde, Désirée

“…Abstract Objectives To investigate in patients with chronic back pain of a short duration, the utility of adding structural MRI lesions of the SI joints to the…”
Get full text

Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive by Ez-Zaitouni, Zineb, Landewé, Robert, van Lunteren, Miranda, Bakker, Pauline A, Fagerli, Karen M, Ramonda, Roberta, Jacobsson, Lennart T H, van der Heijde, Désirée, van Gaalen, Floris A

“…Abstract Objectives To evaluate the contribution of the results of sacroiliac imaging to diagnosis and to the level of confidence in diagnosis in patients…”
Get full text

First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register by Lie, Elisabeth, Fagerli, Karen M, Mikkelsen, Knut, Rødevand, Erik, Lexberg, Ase, Kalstad, Synøve, Uhlig, Till, Kvien, Tore K

Get more information

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria by FAGERLI, Karen M, LIE, Elisabeth, DER HEIJDE, Desiree Van, HEIBERG, Marte S, KAUFMANN, Cecilie, RØDEVAND, Erik, MIKKELSEN, Knut, KALSTAD, Synove, KVIEN, Tore K

“…To compare Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥2.1 with BASDAI >4 as an eligibility criterion for initiation of TNF inhibitor (TNFi)…”
Get full text

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD) by Mielnik, Pawel, Sexton, Joseph, Fagerli, Karen M, Bakland, Gunnstein, Hu, Yi, Kristianslund, Eirik K, Hoff, Mari, Wierød, Ada, Kvien, Tore K

“…Abstract Objectives MTX, LEF and SSZ are conventional synthetic DMARDs (csDMARDs) with a well-established role in the treatment of RA. We aimed to estimate and…”
Get full text

Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study by Fagerli, Karen M., van der Heijde, Désirée, Heiberg, Marte S., Wierød, Ada, Kalstad, Synøve, Rødevand, Erik, Mikkelsen, Knut, Kvien, Tore K., Lie, Elisabeth

“…Objectives. The objectives of this study were to characterize patients with predominantly axial SpA who received SSZ as their first DMARD, compare the response…”
Get full text

i017 The effectivness and safety of TNFi in patients with severe polyarticular PsA by Fagerli, Karen M

Get full text

OA18 Smoking and high BMI are associated with reductions in TNF inhibitor response in psoriatic arthritis: results from 12 European countries by Jones, Gareth T, Rotariu, Ovidiu, Michelsen, Brigitte, Glintborg, Bente, Gudbjornsson, Bjorn, Love, Thorvardur J, Nordström, Dan, Sokka, Tuulikki, Vencovský, Jiří, Horák, Pavel, Rotar, Ziga, Tomšič, Matija, van der Sande, Marleen, Nissen, Michael J, Möller, Burkhard, Codreanu, Catalin, Wallman, Johan K, Fagerli, Karen M, Rasmussen, Simon H, Ørnbjerg, Lykke M, Santos, Maria J, Carvalho, Pedro, Hetland, Merete L, Østergaard, Mikkel, Macfarlane, Gary J

“…Abstract Background/Aims In axial spondyloarthritis, it has been shown that while some adverse lifestyle factors (smoking and high body mass index (BMI)) are…”
Get full text